0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global BDZs Drugs Market Research Report 2025
Published Date: 2025-02-21
|
Report Code: QYRE-Auto-1Z19055
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global BDZs Drugs Market Research Report 2025
BUY CHAPTERS

Global BDZs Drugs Market Research Report 2025

Code: QYRE-Auto-1Z19055
Report
2025-02-21
Pages:113
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

BDZs Drugs Market Size

The global market for BDZs Drugs was valued at US$ 2069 million in the year 2024 and is projected to reach a revised size of US$ 4393 million by 2031, growing at a CAGR of 11.5% during the forecast period.

BDZs Drugs Market

BDZs Drugs Market

Benzodiazepines (BZDs, benzos), also known as benzodiazepines, are a class of central nervous system depressant drugs with a core chemical structure consisting of a fusion of a benzene ring and a diazepine ring. They are a type of psychotropic drug and are often used as sedatives and hypnotics. They are also used as anti-epileptic and antianxiety drugs.
North American market for BDZs Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for BDZs Drugs is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of BDZs Drugs include Pfizer, Teva, Torrent Pharma, Roche, Akorn, Apotex, Fresenius Kabi, Hikma, Mylan, Par Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for BDZs Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BDZs Drugs.
The BDZs Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global BDZs Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BDZs Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of BDZs Drugs Market Report

Report Metric Details
Report Name BDZs Drugs Market
Accounted market size in year US$ 2069 million
Forecasted market size in 2031 US$ 4393 million
CAGR 11.5%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Oral
  • Injection
Segment by Application
  • Anxiety Disorders
  • Insomnia
  • Muscle Spasms
  • Alcohol Withdrawal Syndrome
  • Epilepsy
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Teva, Torrent Pharma, Roche, Akorn, Apotex, Fresenius Kabi, Hikma, Mylan, Par Pharmaceuticals, Sandoz, Sun Pharma, WG Critical Care, Takeda, Shanghai Pharmaceuticals Holding, CHEPLAPHARM, Neurelis, ANI Pharmaceuticals, Bausch Health, Huazhong Pharmaceutical, Kaifeng Pharmaceutical, Changzhou Siyao Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of BDZs Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of BDZs Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is BDZs Drugs Market growing?

Ans: The BDZs Drugs Market witnessing a CAGR of 11.5% during the forecast period 2025-2031.

What is the BDZs Drugs Market size in 2031?

Ans: The BDZs Drugs Market size in 2031 will be US$ 4393 million.

Who are the main players in the BDZs Drugs Market report?

Ans: The main players in the BDZs Drugs Market are Pfizer, Teva, Torrent Pharma, Roche, Akorn, Apotex, Fresenius Kabi, Hikma, Mylan, Par Pharmaceuticals, Sandoz, Sun Pharma, WG Critical Care, Takeda, Shanghai Pharmaceuticals Holding, CHEPLAPHARM, Neurelis, ANI Pharmaceuticals, Bausch Health, Huazhong Pharmaceutical, Kaifeng Pharmaceutical, Changzhou Siyao Pharmaceutical

What are the Application segmentation covered in the BDZs Drugs Market report?

Ans: The Applications covered in the BDZs Drugs Market report are Anxiety Disorders, Insomnia, Muscle Spasms, Alcohol Withdrawal Syndrome, Epilepsy, Other

What are the Type segmentation covered in the BDZs Drugs Market report?

Ans: The Types covered in the BDZs Drugs Market report are Oral, Injection

1 BDZs Drugs Market Overview
1.1 Product Definition
1.2 BDZs Drugs by Type
1.2.1 Global BDZs Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Injection
1.3 BDZs Drugs by Application
1.3.1 Global BDZs Drugs Market Value by Application (2024 VS 2031)
1.3.2 Anxiety Disorders
1.3.3 Insomnia
1.3.4 Muscle Spasms
1.3.5 Alcohol Withdrawal Syndrome
1.3.6 Epilepsy
1.3.7 Other
1.4 Global BDZs Drugs Market Size Estimates and Forecasts
1.4.1 Global BDZs Drugs Revenue 2020-2031
1.4.2 Global BDZs Drugs Sales 2020-2031
1.4.3 Global BDZs Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 BDZs Drugs Market Competition by Manufacturers
2.1 Global BDZs Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global BDZs Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global BDZs Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of BDZs Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of BDZs Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of BDZs Drugs, Product Type & Application
2.7 Global Key Manufacturers of BDZs Drugs, Date of Enter into This Industry
2.8 Global BDZs Drugs Market Competitive Situation and Trends
2.8.1 Global BDZs Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest BDZs Drugs Players Market Share by Revenue
2.8.3 Global BDZs Drugs Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global BDZs Drugs Market Scenario by Region
3.1 Global BDZs Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global BDZs Drugs Sales by Region: 2020-2031
3.2.1 Global BDZs Drugs Sales by Region: 2020-2025
3.2.2 Global BDZs Drugs Sales by Region: 2026-2031
3.3 Global BDZs Drugs Revenue by Region: 2020-2031
3.3.1 Global BDZs Drugs Revenue by Region: 2020-2025
3.3.2 Global BDZs Drugs Revenue by Region: 2026-2031
3.4 North America BDZs Drugs Market Facts & Figures by Country
3.4.1 North America BDZs Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America BDZs Drugs Sales by Country (2020-2031)
3.4.3 North America BDZs Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe BDZs Drugs Market Facts & Figures by Country
3.5.1 Europe BDZs Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe BDZs Drugs Sales by Country (2020-2031)
3.5.3 Europe BDZs Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BDZs Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific BDZs Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific BDZs Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific BDZs Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America BDZs Drugs Market Facts & Figures by Country
3.7.1 Latin America BDZs Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America BDZs Drugs Sales by Country (2020-2031)
3.7.3 Latin America BDZs Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa BDZs Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa BDZs Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa BDZs Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa BDZs Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global BDZs Drugs Sales by Type (2020-2031)
4.1.1 Global BDZs Drugs Sales by Type (2020-2025)
4.1.2 Global BDZs Drugs Sales by Type (2026-2031)
4.1.3 Global BDZs Drugs Sales Market Share by Type (2020-2031)
4.2 Global BDZs Drugs Revenue by Type (2020-2031)
4.2.1 Global BDZs Drugs Revenue by Type (2020-2025)
4.2.2 Global BDZs Drugs Revenue by Type (2026-2031)
4.2.3 Global BDZs Drugs Revenue Market Share by Type (2020-2031)
4.3 Global BDZs Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global BDZs Drugs Sales by Application (2020-2031)
5.1.1 Global BDZs Drugs Sales by Application (2020-2025)
5.1.2 Global BDZs Drugs Sales by Application (2026-2031)
5.1.3 Global BDZs Drugs Sales Market Share by Application (2020-2031)
5.2 Global BDZs Drugs Revenue by Application (2020-2031)
5.2.1 Global BDZs Drugs Revenue by Application (2020-2025)
5.2.2 Global BDZs Drugs Revenue by Application (2026-2031)
5.2.3 Global BDZs Drugs Revenue Market Share by Application (2020-2031)
5.3 Global BDZs Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer BDZs Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Teva
6.2.1 Teva Company Information
6.2.2 Teva Description and Business Overview
6.2.3 Teva BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva BDZs Drugs Product Portfolio
6.2.5 Teva Recent Developments/Updates
6.3 Torrent Pharma
6.3.1 Torrent Pharma Company Information
6.3.2 Torrent Pharma Description and Business Overview
6.3.3 Torrent Pharma BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Torrent Pharma BDZs Drugs Product Portfolio
6.3.5 Torrent Pharma Recent Developments/Updates
6.4 Roche
6.4.1 Roche Company Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Roche BDZs Drugs Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Akorn
6.5.1 Akorn Company Information
6.5.2 Akorn Description and Business Overview
6.5.3 Akorn BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Akorn BDZs Drugs Product Portfolio
6.5.5 Akorn Recent Developments/Updates
6.6 Apotex
6.6.1 Apotex Company Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Apotex BDZs Drugs Product Portfolio
6.6.5 Apotex Recent Developments/Updates
6.7 Fresenius Kabi
6.7.1 Fresenius Kabi Company Information
6.7.2 Fresenius Kabi Description and Business Overview
6.7.3 Fresenius Kabi BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Fresenius Kabi BDZs Drugs Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 Hikma
6.8.1 Hikma Company Information
6.8.2 Hikma Description and Business Overview
6.8.3 Hikma BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hikma BDZs Drugs Product Portfolio
6.8.5 Hikma Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Company Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Mylan BDZs Drugs Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Par Pharmaceuticals
6.10.1 Par Pharmaceuticals Company Information
6.10.2 Par Pharmaceuticals Description and Business Overview
6.10.3 Par Pharmaceuticals BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Par Pharmaceuticals BDZs Drugs Product Portfolio
6.10.5 Par Pharmaceuticals Recent Developments/Updates
6.11 Sandoz
6.11.1 Sandoz Company Information
6.11.2 Sandoz Description and Business Overview
6.11.3 Sandoz BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Sandoz BDZs Drugs Product Portfolio
6.11.5 Sandoz Recent Developments/Updates
6.12 Sun Pharma
6.12.1 Sun Pharma Company Information
6.12.2 Sun Pharma Description and Business Overview
6.12.3 Sun Pharma BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Sun Pharma BDZs Drugs Product Portfolio
6.12.5 Sun Pharma Recent Developments/Updates
6.13 WG Critical Care
6.13.1 WG Critical Care Company Information
6.13.2 WG Critical Care Description and Business Overview
6.13.3 WG Critical Care BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 WG Critical Care BDZs Drugs Product Portfolio
6.13.5 WG Critical Care Recent Developments/Updates
6.14 Takeda
6.14.1 Takeda Company Information
6.14.2 Takeda Description and Business Overview
6.14.3 Takeda BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Takeda BDZs Drugs Product Portfolio
6.14.5 Takeda Recent Developments/Updates
6.15 Shanghai Pharmaceuticals Holding
6.15.1 Shanghai Pharmaceuticals Holding Company Information
6.15.2 Shanghai Pharmaceuticals Holding Description and Business Overview
6.15.3 Shanghai Pharmaceuticals Holding BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shanghai Pharmaceuticals Holding BDZs Drugs Product Portfolio
6.15.5 Shanghai Pharmaceuticals Holding Recent Developments/Updates
6.16 CHEPLAPHARM
6.16.1 CHEPLAPHARM Company Information
6.16.2 CHEPLAPHARM Description and Business Overview
6.16.3 CHEPLAPHARM BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 CHEPLAPHARM BDZs Drugs Product Portfolio
6.16.5 CHEPLAPHARM Recent Developments/Updates
6.17 Neurelis
6.17.1 Neurelis Company Information
6.17.2 Neurelis Description and Business Overview
6.17.3 Neurelis BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Neurelis BDZs Drugs Product Portfolio
6.17.5 Neurelis Recent Developments/Updates
6.18 ANI Pharmaceuticals
6.18.1 ANI Pharmaceuticals Company Information
6.18.2 ANI Pharmaceuticals Description and Business Overview
6.18.3 ANI Pharmaceuticals BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 ANI Pharmaceuticals BDZs Drugs Product Portfolio
6.18.5 ANI Pharmaceuticals Recent Developments/Updates
6.19 Bausch Health
6.19.1 Bausch Health Company Information
6.19.2 Bausch Health Description and Business Overview
6.19.3 Bausch Health BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Bausch Health BDZs Drugs Product Portfolio
6.19.5 Bausch Health Recent Developments/Updates
6.20 Huazhong Pharmaceutical
6.20.1 Huazhong Pharmaceutical Company Information
6.20.2 Huazhong Pharmaceutical Description and Business Overview
6.20.3 Huazhong Pharmaceutical BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Huazhong Pharmaceutical BDZs Drugs Product Portfolio
6.20.5 Huazhong Pharmaceutical Recent Developments/Updates
6.21 Kaifeng Pharmaceutical
6.21.1 Kaifeng Pharmaceutical Company Information
6.21.2 Kaifeng Pharmaceutical Description and Business Overview
6.21.3 Kaifeng Pharmaceutical BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Kaifeng Pharmaceutical BDZs Drugs Product Portfolio
6.21.5 Kaifeng Pharmaceutical Recent Developments/Updates
6.22 Changzhou Siyao Pharmaceutical
6.22.1 Changzhou Siyao Pharmaceutical Company Information
6.22.2 Changzhou Siyao Pharmaceutical Description and Business Overview
6.22.3 Changzhou Siyao Pharmaceutical BDZs Drugs Sales, Revenue and Gross Margin (2020-2025)
6.22.4 Changzhou Siyao Pharmaceutical BDZs Drugs Product Portfolio
6.22.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BDZs Drugs Industry Chain Analysis
7.2 BDZs Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BDZs Drugs Production Mode & Process Analysis
7.4 BDZs Drugs Sales and Marketing
7.4.1 BDZs Drugs Sales Channels
7.4.2 BDZs Drugs Distributors
7.5 BDZs Drugs Customer Analysis
8 BDZs Drugs Market Dynamics
8.1 BDZs Drugs Industry Trends
8.2 BDZs Drugs Market Drivers
8.3 BDZs Drugs Market Challenges
8.4 BDZs Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global BDZs Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global BDZs Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global BDZs Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global BDZs Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global BDZs Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global BDZs Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global BDZs Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market BDZs Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of BDZs Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of BDZs Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of BDZs Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of BDZs Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global BDZs Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in BDZs Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global BDZs Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global BDZs Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global BDZs Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global BDZs Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global BDZs Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global BDZs Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global BDZs Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global BDZs Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global BDZs Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America BDZs Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America BDZs Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America BDZs Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America BDZs Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America BDZs Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe BDZs Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe BDZs Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe BDZs Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe BDZs Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe BDZs Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific BDZs Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific BDZs Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific BDZs Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific BDZs Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific BDZs Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America BDZs Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America BDZs Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America BDZs Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America BDZs Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America BDZs Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa BDZs Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa BDZs Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa BDZs Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa BDZs Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa BDZs Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global BDZs Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global BDZs Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global BDZs Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global BDZs Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global BDZs Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global BDZs Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global BDZs Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global BDZs Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global BDZs Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global BDZs Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global BDZs Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global BDZs Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global BDZs Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global BDZs Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global BDZs Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global BDZs Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global BDZs Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global BDZs Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global BDZs Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global BDZs Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer BDZs Drugs Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Teva Company Information
 Table 76. Teva Description and Business Overview
 Table 77. Teva BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Teva BDZs Drugs Product
 Table 79. Teva Recent Developments/Updates
 Table 80. Torrent Pharma Company Information
 Table 81. Torrent Pharma Description and Business Overview
 Table 82. Torrent Pharma BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Torrent Pharma BDZs Drugs Product
 Table 84. Torrent Pharma Recent Developments/Updates
 Table 85. Roche Company Information
 Table 86. Roche Description and Business Overview
 Table 87. Roche BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Roche BDZs Drugs Product
 Table 89. Roche Recent Developments/Updates
 Table 90. Akorn Company Information
 Table 91. Akorn Description and Business Overview
 Table 92. Akorn BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Akorn BDZs Drugs Product
 Table 94. Akorn Recent Developments/Updates
 Table 95. Apotex Company Information
 Table 96. Apotex Description and Business Overview
 Table 97. Apotex BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Apotex BDZs Drugs Product
 Table 99. Apotex Recent Developments/Updates
 Table 100. Fresenius Kabi Company Information
 Table 101. Fresenius Kabi Description and Business Overview
 Table 102. Fresenius Kabi BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Fresenius Kabi BDZs Drugs Product
 Table 104. Fresenius Kabi Recent Developments/Updates
 Table 105. Hikma Company Information
 Table 106. Hikma Description and Business Overview
 Table 107. Hikma BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Hikma BDZs Drugs Product
 Table 109. Hikma Recent Developments/Updates
 Table 110. Mylan Company Information
 Table 111. Mylan Description and Business Overview
 Table 112. Mylan BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Mylan BDZs Drugs Product
 Table 114. Mylan Recent Developments/Updates
 Table 115. Par Pharmaceuticals Company Information
 Table 116. Par Pharmaceuticals Description and Business Overview
 Table 117. Par Pharmaceuticals BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Par Pharmaceuticals BDZs Drugs Product
 Table 119. Par Pharmaceuticals Recent Developments/Updates
 Table 120. Sandoz Company Information
 Table 121. Sandoz Description and Business Overview
 Table 122. Sandoz BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Sandoz BDZs Drugs Product
 Table 124. Sandoz Recent Developments/Updates
 Table 125. Sun Pharma Company Information
 Table 126. Sun Pharma Description and Business Overview
 Table 127. Sun Pharma BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Sun Pharma BDZs Drugs Product
 Table 129. Sun Pharma Recent Developments/Updates
 Table 130. WG Critical Care Company Information
 Table 131. WG Critical Care Description and Business Overview
 Table 132. WG Critical Care BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. WG Critical Care BDZs Drugs Product
 Table 134. WG Critical Care Recent Developments/Updates
 Table 135. Takeda Company Information
 Table 136. Takeda Description and Business Overview
 Table 137. Takeda BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Takeda BDZs Drugs Product
 Table 139. Takeda Recent Developments/Updates
 Table 140. Shanghai Pharmaceuticals Holding Company Information
 Table 141. Shanghai Pharmaceuticals Holding Description and Business Overview
 Table 142. Shanghai Pharmaceuticals Holding BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Shanghai Pharmaceuticals Holding BDZs Drugs Product
 Table 144. Shanghai Pharmaceuticals Holding Recent Developments/Updates
 Table 145. CHEPLAPHARM Company Information
 Table 146. CHEPLAPHARM Description and Business Overview
 Table 147. CHEPLAPHARM BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. CHEPLAPHARM BDZs Drugs Product
 Table 149. CHEPLAPHARM Recent Developments/Updates
 Table 150. Neurelis Company Information
 Table 151. Neurelis Description and Business Overview
 Table 152. Neurelis BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Neurelis BDZs Drugs Product
 Table 154. Neurelis Recent Developments/Updates
 Table 155. ANI Pharmaceuticals Company Information
 Table 156. ANI Pharmaceuticals Description and Business Overview
 Table 157. ANI Pharmaceuticals BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 158. ANI Pharmaceuticals BDZs Drugs Product
 Table 159. ANI Pharmaceuticals Recent Developments/Updates
 Table 160. Bausch Health Company Information
 Table 161. Bausch Health Description and Business Overview
 Table 162. Bausch Health BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 163. Bausch Health BDZs Drugs Product
 Table 164. Bausch Health Recent Developments/Updates
 Table 165. Huazhong Pharmaceutical Company Information
 Table 166. Huazhong Pharmaceutical Description and Business Overview
 Table 167. Huazhong Pharmaceutical BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 168. Huazhong Pharmaceutical BDZs Drugs Product
 Table 169. Huazhong Pharmaceutical Recent Developments/Updates
 Table 170. Kaifeng Pharmaceutical Company Information
 Table 171. Kaifeng Pharmaceutical Description and Business Overview
 Table 172. Kaifeng Pharmaceutical BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 173. Kaifeng Pharmaceutical BDZs Drugs Product
 Table 174. Kaifeng Pharmaceutical Recent Developments/Updates
 Table 175. Changzhou Siyao Pharmaceutical Company Information
 Table 176. Changzhou Siyao Pharmaceutical Description and Business Overview
 Table 177. Changzhou Siyao Pharmaceutical BDZs Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 178. Changzhou Siyao Pharmaceutical BDZs Drugs Product
 Table 179. Changzhou Siyao Pharmaceutical Recent Developments/Updates
 Table 180. Key Raw Materials Lists
 Table 181. Raw Materials Key Suppliers Lists
 Table 182. BDZs Drugs Distributors List
 Table 183. BDZs Drugs Customers List
 Table 184. BDZs Drugs Market Trends
 Table 185. BDZs Drugs Market Drivers
 Table 186. BDZs Drugs Market Challenges
 Table 187. BDZs Drugs Market Restraints
 Table 188. Research Programs/Design for This Report
 Table 189. Key Data Information from Secondary Sources
 Table 190. Key Data Information from Primary Sources
 Table 191. Authors List of This Report


List of Figures
 Figure 1. Product Picture of BDZs Drugs
 Figure 2. Global BDZs Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global BDZs Drugs Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global BDZs Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global BDZs Drugs Market Share by Application: 2024 & 2031
 Figure 8. Anxiety Disorders
 Figure 9. Insomnia
 Figure 10. Muscle Spasms
 Figure 11. Alcohol Withdrawal Syndrome
 Figure 12. Epilepsy
 Figure 13. Other
 Figure 14. Global BDZs Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global BDZs Drugs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global BDZs Drugs Sales (2020-2031) & (K Units)
 Figure 17. Global BDZs Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 18. BDZs Drugs Report Years Considered
 Figure 19. BDZs Drugs Sales Share by Manufacturers in 2024
 Figure 20. Global BDZs Drugs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest BDZs Drugs Players: Market Share by Revenue in BDZs Drugs in 2024
 Figure 22. BDZs Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global BDZs Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America BDZs Drugs Sales Market Share by Country (2020-2031)
 Figure 25. North America BDZs Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. United States BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe BDZs Drugs Sales Market Share by Country (2020-2031)
 Figure 29. Europe BDZs Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. Germany BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific BDZs Drugs Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific BDZs Drugs Revenue Market Share by Region (2020-2031)
 Figure 37. China BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. China Taiwan BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Southeast Asia BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America BDZs Drugs Sales Market Share by Country (2020-2031)
 Figure 45. Latin America BDZs Drugs Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Colombia BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa BDZs Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa BDZs Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE BDZs Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of BDZs Drugs by Type (2020-2031)
 Figure 56. Global Revenue Market Share of BDZs Drugs by Type (2020-2031)
 Figure 57. Global BDZs Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of BDZs Drugs by Application (2020-2031)
 Figure 59. Global Revenue Market Share of BDZs Drugs by Application (2020-2031)
 Figure 60. Global BDZs Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 61. BDZs Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS